Alternatively spliced human tissue factor promotes tumor growth and angiogenesis in a pancreatic cancer tumor model

Jennifer E. Hobbs, Anaadriana Zakarija, Deborah L. Cundiff, Jennifer A. Doll, Emily Hymen, Mona Cornwell, Susan E. Crawford, Na Liu, Maxim Signaevsky, Gerald A. Soff*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

73 Scopus citations

Abstract

Introduction: Tissue Factor (TF) expression is observed in many types of cancer, associated with more aggressive disease, and thrombosis. Alternatively-spliced human tissue factor (asHTF) has recently been identified in which exon 5 is deleted. asHTF is soluble due to the substitution of the transmembrane and cytoplasmic domains of exon 6 with a unique COOH-terminal domain. Materials and Methods: We examine the expression and function of asHTF and full-length Tissue Factor (FLTF) in six human pancreatic cancer cells. Further, we transfected asHTF, FLTF, and control expression vectors into a non-expressing, human pancreatic cancer line (MiaPaCa-2). We studied the procoagulant activity of asHTF and flTF and the effect on tumor growth in mice. Results: asHTF is expressed in 5 of 6 human pancreatic cancer cell lines, but not in normal human fibroblasts, nor the MiaPaCa-2 line. flTF conferred procoagulant activity, but asHTF did not. Transfected cells were injected subcutaneously in athymic mice. Interestingly, compared with control transfection, flTF expression was associated with reduced tumor growth (mean 7 mg vs 85 mg), while asHTF-expression was associated with enhanced tumor growth (mean 389 mg vs. 85 mg). asHTF expression resulted in increased mitotic index and microvascular density. Conclusions: These data suggests that asHTF expression promotes tumor growth, and is associated with increased tumor cell proliferation and angiogenesis in vivo. Our results raise a new perspective on the understanding of the relationship between TF expression and cancer growth, by showing a dissociation of the procoagulant activity of flTF and the cancer-promoting activity of asHTF.

Original languageEnglish (US)
Pages (from-to)S13-S21
JournalThrombosis research
Volume120
Issue numberSUPPL. 2
DOIs
StatePublished - 2007

Keywords

  • Alternatively spliced human tissue factor
  • Cancer
  • Coagulation
  • Thrombosis
  • Tissue factor

ASJC Scopus subject areas

  • Hematology

Fingerprint

Dive into the research topics of 'Alternatively spliced human tissue factor promotes tumor growth and angiogenesis in a pancreatic cancer tumor model'. Together they form a unique fingerprint.

Cite this